From circulating signals to spatial context: Multiomic insights for next‑generation cancer research

Multiomics is advancing cancer research at an unprecedented scale, opening new ways to understand disease and improving how we detect and track it. This symposium brings together two exciting areas driving that progress: multiomic liquid biopsy, combining DNA and methylation signals for deeper biological insights into disease detection and progression, and spatial transcriptomics, which helps reveal how cells are organized and interact within the tumor microenvironment (TME).

We will share updates on Illumina innovations that connect these layers of biology, along with customer examples in 5-base, methylation-aware liquid biopsy, and spatially resolved expression mapping. Join us to explore how integrated multiomics can sharpen detection, bring tumor ecosystems into a clearer view, and accelerate translational discoveries.

Note: Registration on this page is for the on-demand webinar (recording) only. There is no live stream. The recording will be available on demand after the event.

Featured speakers

David Spencer, MD, PhD
Assoc Professor, Division of Oncology
Washington University School of Medicine

Claire Mills, DDS
PhD Candidate
Oral Health Sciences, University of Washington / Fred Hutchinson Cancer Center, Setty & Beronja Labs

Richard Capper, PhD
Sr Dir, Global Research Customer Marketing
Illumina